The immunomodulatory effect of continuous ultrafiltration during pediatric cardiac surgery

Joel David Bierer1, Roger Stanzel2, Mark Henderson2

  • 1Division of Cardiac Surgery, Dalhousie University, Halifax, Canada.

Perfusion
|September 1, 2025
PubMed

Insights

Ultrafiltration during pediatric cardiopulmonary bypass (CPB) shows limited effectiveness in removing inflammatory mediators. Only complement component C3a was significantly extracted by ultrafiltration, suggesting minimal immunologic benefit in pediatric cardiac surgery.

Area of Science:

  • Cardiovascular Surgery
  • Immunology
  • Pediatric Critical Care

Background:

  • Pediatric cardiac surgery utilizing cardiopulmonary bypass (CPB) is linked to systemic inflammation.
  • Elevated levels of complement, cytokines, and chemokines are characteristic of CPB-associated inflammation.
  • The immunologic efficacy of continuous ultrafiltration (UF) during CPB requires quantification.

Purpose of the Study:

  • To quantify the immunologic efficacy of ultrafiltration (UF) during pediatric cardiopulmonary bypass (CPB).
  • To assess the removal of inflammatory mediators by UF during CPB in pediatric patients.

Main Methods:

  • A prospective, single-arm clinical study involving pediatric patients undergoing cardiac surgery with CPB.
  • Continuous ultrafiltration (subzero-balance UF and conventional UF) was applied during CPB.
  • Measurement of 33 inflammatory mediators in arterial and UF effluent samples.
  • Exploratory counterfactual analysis using AUC, GLMEM, and median fold change to compare UF vs. no UF.

Main Results:

  • Forty pediatric patients were enrolled; data on inflammatory mediator concentrations were collected.
  • Multiple inflammatory mediators including cytokines and chemokines were detected in UF effluent.
  • Counterfactual analysis revealed significant removal of complement component C3a by UF (p < 3.5 × 10⁻¹²).

Conclusions:

  • Continuous ultrafiltration during pediatric CPB demonstrates limited effectiveness in extracting inflammatory mediators.
  • C3a was the sole inflammatory mediator significantly removed from circulation by UF in this study.
  • Further research may be needed to optimize UF strategies for managing inflammation during pediatric CPB.

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
129
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
80
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72